CIK 0001439725 · Services-Medical Laboratories (SIC 8071) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Revenue (USD) | 88.5 M | 49.1 M | 38.2 M | |
| Net income (USD) | -52.1 M | -65.4 M | -43.2 M | |
| Diluted EPS (USD/shares) | -4.67 | -0.64 | -1.55 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-02 | 4 | FORM 4 | 2026-09-30 |
| 2026-08-13 | 4 | FORM 4 | 2026-08-12 |
| 2026-08-12 | 4 | FORM 4 | 2026-08-10 |
| 2026-08-05 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-05 | 8-K | 8-K items 2.02,9.01 | 2026-08-05 |
| 2026-07-02 | 4 | FORM 4 | 2026-06-30 |
| 2026-06-18 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-06-01 | 424B3 | 424B3 | |
| 2026-05-29 | EFFECT | EFFECT items ,, | |
| 2026-05-27 | CORRESP | CORRESP | |
| 2026-05-26 | UPLOAD | UPLOAD | |
| 2026-05-21 | S-3 | S-3 | |
| 2026-05-20 | 8-K | 8-K items 5.07,9.01 | 2026-05-19 |
| 2026-05-15 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-05-08 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-05-04 | 10-Q | 10-Q | 2026-03-31 |
| 2026-05-04 | 8-K | 8-K items 2.02,9.01 | 2026-05-04 |
| 2026-04-28 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-04-09 | ARS | ARS | 2025-12-31 |
| 2026-04-09 | DEFA14A | DEFA14A | |
| 2026-04-09 | DEF 14A | DEF 14A | 2026-05-19 |
| 2026-04-02 | 4 | FORM 4 | 2026-03-31 |
| 2026-02-26 | 10-K | 10-K | 2025-12-31 |
| 2026-02-26 | 8-K | 8-K items 2.02,9.01 | 2026-02-26 |
| 2026-02-23 | 4 | FORM 4 | 2026-02-20 |
Forms on file (last 1,000): 4 318, 8-K 54, D 20, 10-Q 18, 144 17, 3 15, CORRESP 14, SC 13D/A 14. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=BDSX (0.002 USD), /gw/filings/filings?ticker=BDSX&form=8-K, /gw/filings/facts?ticker=BDSX&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange